Sponsored by:

Nuclear Medicine: Page 138

Road to RSNA 2014: Molecular Imaging Preview
By Wayne Forrest
At the 100th annual meeting of RSNA, molecular imaging and nuclear medicine again will break new ground for an increasing number of clinical applications to better serve patients. Leading the charge is PET/MRI. The hybrid's functional and structural imaging capabilities have captured the imagination of researchers worldwide, resulting in a growing number of scientific research papers this year dedicated to the modality.
November 4, 2014
2014 11 03 11 22 44 485 Road To Rsna 200
PET/MRI compares well with PET/CT for pancreatic cancer
By Wayne Forrest
Thursday, December 4 | 11:40 a.m.-11:50 a.m. | SSQ06-08 | Room E350Italian researchers are adding to the evidence that PET/MRI can benefit cancer patients for use in tumor-node-metastasis staging.
November 4, 2014
PET/MRI adds to lung cancer diagnoses
By Wayne Forrest
Wednesday, December 3 | 11:40 a.m.-11:50 a.m. | SSK18-08 | Room S505ABBritish researchers have concluded that PET/MRI appears to be a "robust technique" for preoperative staging of lung cancer patients, offering "significantly lower radiation dose."
November 4, 2014
Researchers make PET/MRI scans more tolerable for young patients
By Wayne Forrest
Wednesday, December 3 | 11:30 a.m.-11:40 a.m. | SSK18-07 | Room S505ABResearchers at Lucile Packard Children's Hospital and Stanford University School of Medicine have found a way to streamline FDG-PET/MRI scans to make them more tolerable for children with lymphoma and sarcoma.
November 4, 2014
Infants with congenital hyperinsulinism can benefit from PET/MRI
By Wayne Forrest
Wednesday, December 3 | 11:20 a.m.-11:30 a.m. | SSK19-06 | Room S102ABSimultaneous PET/MRI with fluorine-18 dihydroxyphenylalanine matches PET/CT in the preoperative differentiation of congenital hyperinsulinism among pediatric patients -- while delivering less radiation.
November 4, 2014
Time-of-flight PET/MRI could help with a variety of clinical applications
By Wayne Forrest
Wednesday, December 3 | 11:10 a.m.-11:20 a.m. | SSK18-05 | Room S505ABTime-of-flight PET/MRI provided comparable image quality and diagnostic ability to PET/CT in several clinical applications in a study from Stanford University.
November 4, 2014
DOTATOC-PET/CT appears better at sarcoidosis lesion detection
By Wayne Forrest
Tuesday, December 2 | 3:10 p.m.-3:20 p.m. | SSJ20-02 | Room S505ABResearchers were able to detect more lesions in sarcoidosis patients using PET/CT with gallium-68 DOTATOC than conventional gallium-67 citrate scintigraphy in this study from Kyoto University in Japan.
November 4, 2014
PET/MRI provides partial benefit for soft-tissue sarcoma patients
By Wayne Forrest
Sunday, November 30 | 12:05 p.m.-12:15 p.m. | SSA13-09 | Room E451BGerman researchers are lauding the ability of PET/MRI to provide "superior assessment" of therapy based on functional metabolic response, but morphologic information falls short in evaluating therapeutic response in soft-tissue sarcoma patients after isolated limb perfusion.
November 4, 2014
FDG-PET/CT offers insight into thyroid cancer patient survival
By Wayne Forrest
Sunday, November 30 | 11:25 a.m.-11:35 a.m. | SSA18-05 | Room S505ABFDG-PET/CT scans conducted more than six months after primary thyroid cancer treatment can enhance a patient's clinical evaluation and provide a prognostic marker of overall survival, according to this study from Johns Hopkins University.
November 4, 2014
Lantheus inks Mo-99 supply deal with Shine
By AuntMinnie.com staff writers
Lantheus Medical Imaging has signed an agreement with Shine Medical Technologies covering the supply of molybdenum-99 (Mo-99).
November 3, 2014
Digirad urges PDI to reconsider offer
By AuntMinnie.com staff writers
Digirad has sent a letter to healthcare commercialization services company PDI urging it to reconsider an acquisition offer from Digirad that PDI summarily rejected within hours after receipt on October 29.
November 2, 2014
PDI rebuffs Digirad's acquisition offer
By AuntMinnie.com staff writers
Healthcare commercialization services company PDI has rebuffed an acquisition offer from nuclear medicine firm Digirad.
October 29, 2014
Previous Page
Page 138 of 438
Next Page